A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the
Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan
160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers